- 期刊
Mycobacterium tuberculosis H37Rv: In Silico Drug Targets Identification by Metabolic Pathways Analysis
延伸閱讀
- Bermudez, L. E., & Meek, L. (2014). Mefloquine and Its Enantiomers Are Active against ＂Mycobacterium tuberculosis＂ In Vitro and in Macrophages. Tuberculosis Research and Treatment, (2014), 115-119. https://doi.org/10.1155/2014/530815
- Gordon, S., Simithy, J., Goodwin, D. C., & Calderón, A. I. (2015). Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials. Perspectives in Medicinal Chemistry, (2015), 9-20. https://doi.org/10.4137/PMC.S13212
- Tung, Y. C. (2016). The research of mycobacterium tuberculosis antigen presentation by monocytes from tuberculosis patients [doctoral dissertation, Kaohsiung Medical University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0011-2408201617535900
- Lam, T. H. (2011). The study of virulence determinants of mycobacterium tuberculosis [doctoral dissertation, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200020434
- Cheng, W. S. (2012). Rapid diagnosis of isoniazid resistant mycobacterium tuberculosis by hybridization probe based real time PCR [master's thesis, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200020122